Business · 31/01/2022
FDA Renews Vaccines and Related Biological Products Advisory Committee for 2 Years
The FDA has renewed the Vaccines and Related Biological Products Advisory Committee for an additional 2 years, with the new charter set to expire on December 31, 2023, following a determination by the Commissioner of Food and Drugs that it is in the public interest to do so.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →